| 000 | 01776 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514224510.0 | ||
| 264 | 0 | _c20060120 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/01.WNL.0000158476.74580.A8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoxer, A L | |
| 245 | 0 | 0 |
_aExecutive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment. _h[electronic resource] |
| 260 |
_bNeurology _cApr 2005 |
||
| 300 |
_a1431-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aBetaine _xtherapeutic use |
| 650 | 0 | 4 |
_aCognition Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aConfusion _xdrug therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFolic Acid _xtherapeutic use |
| 650 | 0 | 4 |
_aFrontal Lobe _xmetabolism |
| 650 | 0 | 4 |
_aHomocysteine _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperhomocysteinemia _xcomplications |
| 650 | 0 | 4 |
_aLeukoaraiosis _xdiagnosis |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylmalonic Acid _xblood |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aSeizures _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVitamin B 12 _xmetabolism |
| 650 | 0 | 4 |
_aVitamin B 6 _xtherapeutic use |
| 700 | 1 | _aKramer, J H | |
| 700 | 1 | _aJohnston, K | |
| 700 | 1 | _aGoldman, J | |
| 700 | 1 | _aFinley, R | |
| 700 | 1 | _aMiller, B L | |
| 773 | 0 |
_tNeurology _gvol. 64 _gno. 8 _gp. 1431-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/01.WNL.0000158476.74580.A8 _zAvailable from publisher's website |
| 999 |
_c15518925 _d15518925 |
||